Navigation Links
Sangamo BioSciences to Acquire Ceregene
Date:8/26/2013

RICHMOND, Calif., Aug. 26, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus (AAV) gene therapies.  Sangamo will host a teleconference at 8:30 am ET tomorrow, Tuesday, August 27, 2013, to discuss the acquisition and provide a general business overview.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

"Ceregene is a leader in development and manufacturing of AAV-based therapies with significant clinical development experience," said Edward Lanphier, Sangamo's president and CEO.  "Since their inception in 2001, the company has safely treated over 115 subjects in four clinical trials. Sangamo has acquired all of Ceregene's AAV assets including CERE-110, AAV delivery of nerve growth factor (NGF) to the brain for the treatment of Alzheimer's disease.  CERE-110 is being evaluated in a fully enrolled and fully funded Phase 2 clinical trial. In addition to the AAV platform, the assets also include one of the world's largest databases of AAV GMP manufacturing know-how, toxicology data, and safety data from their human clinical trials, which will be an invaluable resource as we advance our ZFP Therapeutics."

Under the terms of the definitive agreement Sangamo will issue to the stockholders of Ceregene 100,000 shares of Sangamo's common stock, which represents less than 0.2 percent of Sangamo's total shares outstanding.  In addition, Sangamo has agreed to make contingent earn-out payments to the stockholders of Ceregene based upon revenues generated from license or sales transaction of certain existing products of Ceregene.  The acquisition is
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
2. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
3. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
4. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
5. Sangamo BioSciences Reports First Quarter 2013 Financial Results
6. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
9. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
10. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
11. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... 2015  Konica Minolta, Inc. (Konica Minolta) ( ... acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer ... through its Brazilian healthcare sales company, Konica Minolta Healthcare ... Brazil market investment and growth ... 200 million, significant healthcare technical advancements and efficiencies are ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... ... After conducting a nationwide executive search led by healthcare leadership solutions ... hired Robert Trenschel, DO, as chief executive officer. A veteran physician executive with 20 ... duties at Yuma Regional Medical Center on July 13. , “Dr. Trenschel brings an ...
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... July 02, 2015 ... ... and the overall status of the Gelatin Capsule manufacturers. The report is a ... industry. , The report depicts the global and Chinese market for the Gelatin ...
(Date:7/2/2015)... ... July 02, 2015 , ... Evolved ... with their launch an intention to partner with companies that share a similar ... planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are ...
(Date:7/2/2015)... AL (PRWEB) , ... July 02, 2015 , ... Every year, DUI arrests and fatalities ... July may be the deadliest day of the year when it comes to being on ... “The National Highway Traffic Safety Association reports that 40% of all highway deaths between 2007 ...
Breaking Medicine News(10 mins):Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:Attorney David Maloney Stresses Safety through Sobriety 2
... , FRIDAY, Sept. 2 (HealthDay News) -- Climate ... departments in the next decade. The prediction was ... regional and atmospheric models. They linked N.Y. State Department ... on asthma-related emergency department visits by children in 14 ...
... to predict which heart transplant patients are at greatest risk ... could help medical teams figure out who would benefit most ... are a limited resource," says John V. Conte, M.D., a ... Medicine and the senior author of the study. "Now, we ...
... News) -- Researchers using scanning technology say they discovered ... autism compared to those of kids without autism. ... children with 92 percent accuracy," based on the volume ... Lucina Uddin, first author of a new study and ...
... (HealthDay News) -- A rapid rise in hookah use in California ... water pipe used for smoking tobacco. An analysis of state data ... more than 40 percent between 2005 and 2008. In 2008, ... higher (24.5 percent of men, 10 percent of women) than it ...
... (HealthDay News) -- Traffic safety should be among a child,s first ... in the United States, more than 25,000 pedestrians aged 5 to ... and Prevention. "Kids who are struck by cars are among ... Because of their height, when a car hits a child, the ...
... Ian Roberts, Head of the World Health Organisation Collaborating Centre ... Tropical Medicine, the recent episode ("Big Lies, Small Lies") seriously ... VIIa (the drug presented in the programme) was shown to ... clotting but it has never been shown to save lives. ...
Cached Medicine News:Health News:Researchers develop new way to predict heart transplant survival 2Health News:Brain Scans Show Distinct Traits in Kids With Autism: Study 2Health News:Hookah Use Growing Among Young Adults in California 2Health News:Traffic Safety Should Be Among First Lessons in New School Year 2Health News:Trauma experts criticize BBC's Holby City for 'peddling dangerous drugs' 2
... The quanTtest human protein standards are available ... 100 and 200 mg/dL and are packaged ... liquid, ready-to-use, requiring no reconstitution or dilution ... using purified human albumin and human globulin ...
... binding method provides a simple, ready-to-use ... with greater linearity, using microliter samples ... in manual or automated systems. Assay ... 2, 3, 4 & 5), reagents, ...
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
The Clearblue Easy Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the 2 best ...
Medicine Products: